Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Versus Aspirin and Fondaparinux Prior to Early Invasive Strategy in Patients With NSTEMI

NCT06710184 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06710184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Versus Aspirin and Fondaparinux Prior to Early Invasive Strategy in Patients With NSTEMI
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2025
Completion date
July 1, 2029
Enrollment
5,076 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), nstemi - non-st segment elevation myocardial infarction (mi)